Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2008 2
2009 1
2012 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Budesonide use in pediatric Crohn disease.
Otley A, LeLeiko N, Langton C, Lerer T, Mack D, Evans J, Pfefferkorn M, Carvalho R, Rosh J, Griffiths A, Oliva-Hemker M, Kay M, Bousvaros A, Stephens M, Samson C, Grossman A, Keljo D, Markowitz J, Hyams J; Pediatric IBD Collaborative Research Group. Otley A, et al. J Pediatr Gastroenterol Nutr. 2012 Aug;55(2):200-4. doi: 10.1097/MPG.0b013e31824a09c2. J Pediatr Gastroenterol Nutr. 2012. PMID: 22258289
Appraisal of the pediatric ulcerative colitis activity index (PUCAI).
Turner D, Hyams J, Markowitz J, Lerer T, Mack DR, Evans J, Pfefferkorn M, Rosh J, Kay M, Crandall W, Keljo D, Otley AR, Kugathasan S, Carvalho R, Oliva-Hemker M, Langton C, Mamula P, Bousvaros A, LeLeiko N, Griffiths AM; Pediatric IBD Collaborative Research Group. Turner D, et al. Inflamm Bowel Dis. 2009 Aug;15(8):1218-23. doi: 10.1002/ibd.20867. Inflamm Bowel Dis. 2009. PMID: 19161178
Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease.
Otley AR, Griffiths AM, Hale S, Kugathasan S, Pfefferkorn M, Mezoff A, Rosh J, Tolia V, Markowitz J, Mack D, Oliva-Hemker M, Wyllie R, Rothbaum R, Bousvaros A, Del Rosario JF, Evans J, Blanchard W, Hyams J; Pediatric IBD Collaborative Research Group. Otley AR, et al. Inflamm Bowel Dis. 2006 Aug;12(8):684-91. doi: 10.1097/00054725-200608000-00003. Inflamm Bowel Dis. 2006. PMID: 16917222
Increased immune reactivity predicts aggressive complicating Crohn's disease in children.
Dubinsky MC, Kugathasan S, Mei L, Picornell Y, Nebel J, Wrobel I, Quiros A, Silber G, Wahbeh G, Katzir L, Vasiliauskas E, Bahar R, Otley A, Mack D, Evans J, Rosh J, Hemker MO, Leleiko N, Crandall W, Langton C, Landers C, Taylor KD, Targan SR, Rotter JI, Markowitz J, Hyams J; Western Regional Pediatric IBD Research Alliance; Pediatric IBD Collaborative Research Group; Wisconsin Pediatric IBD Alliance. Dubinsky MC, et al. Clin Gastroenterol Hepatol. 2008 Oct;6(10):1105-11. doi: 10.1016/j.cgh.2008.04.032. Epub 2008 Jul 10. Clin Gastroenterol Hepatol. 2008. PMID: 18619921 Free PMC article.
Effect of early immunomodulator use in moderate to severe pediatric Crohn disease.
Punati J, Markowitz J, Lerer T, Hyams J, Kugathasan S, Griffiths A, Otley A, Rosh J, Pfefferkorn M, Mack D, Evans J, Bousvaros A, Moyer MS, Wyllie R, Oliva-Hemker M, Mezoff A, Leleiko N, Keljo D, Crandall W; Pediatric IBD Collaborative Research Group. Punati J, et al. Inflamm Bowel Dis. 2008 Jul;14(7):949-54. doi: 10.1002/ibd.20412. Inflamm Bowel Dis. 2008. PMID: 18306311
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease.
Markowitz J, Hyams J, Mack D, Leleiko N, Evans J, Kugathasan S, Pfefferkorn M, Mezoff A, Rosh J, Tolia V, Otley A, Griffiths A, Moyer MS, Oliva-Hemker M, Wyllie R, Rothbaum R, Bousvaros A, Del Rosario JF, Hale S, Lerer T; Pediatric IBD Collaborative Research Group. Markowitz J, et al. Clin Gastroenterol Hepatol. 2006 Sep;4(9):1124-9. doi: 10.1016/j.cgh.2006.05.011. Epub 2006 Jul 24. Clin Gastroenterol Hepatol. 2006. PMID: 16861053